EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BIOREDIS: an integrated platform for end-to-end design of nucleic acid therapeutics

Jakub Kubis iD, Pawel Boinski iD, Maciej Antczak iD, Marek M Figlerowicz iD, Marta Szachniuk iD, Maciej Figiel iD

Bioinformatics · 10.11.2026

DOI: 10.1093/bioinformatics/btag815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 10.11.2026. Verfasst von Jakub Kubis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704, Poznan, Poland. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Motivation Developing state-of-the-art RNA- and DNA-based therapeutics requires advanced computational frameworks that support the entire workflow – from biological rationale to the final drug construct – enabling tissue- and cell-specific targeting with high precision. Existing bioinformatics tools provide only partial solutions and rarely generate designs directly suitable for synthesis or preclinical evaluation. To address these limitations, we present BIOREDIS, a web-based platform for comprehensive nucleic acid therapeutic design. Results BIOREDIS integrates curated data from nine major biological resources and incorporates modules for coding sequence optimization, RNA interference (shRNA/siRNA) design, promoter/UTR selection, and automated construction of viral (AAV, lentiviral), non-viral, and mRNA vaccine vectors. The platform supports designs for human, mouse, and rat, with tissue-specific promoter recommendations available for human and mouse, and advanced cell-expression profiling natively restricted to human. BIOREDIS demonstrates competitive performance in coding sequence optimization and RNAi prediction, while uniquely providing an end-to-end workflow from target selection to fully specified next-generation DNA or RNA therapeutic constructs ready for synthesis and experimental validation. Availability BIOREDIS is freely available at https://rnadrug.ichb.pl/bioredis, with a mirror site at https://bioredis.cs.put.poznan.pl. Supplementary information Supplementary data are available at Bioinformatics online.

Schlagwörter

Stichwörter der Autor:innen

RNA interferencecodon optimizationcomputational drug designmRNA vaccinesnucleic acid therapeutics

Autor:innen und Institutionen

  • Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704, Poznan, Poland.
  • Institute of Computing Science, Poznan University of Technology, Piotrowo 2, 60-965, Poznan, Poland.

ORCID-Profile: Jakub Kubis, Pawel Boinski, Maciej Antczak, Marek M Figlerowicz, Marta Szachniuk, Maciej Figiel

Zitieren

APA

Kubis, J., Boinski, P., Antczak, M., Figlerowicz, M. M., Szachniuk, M., & Figiel, M. (2026). BIOREDIS: an integrated platform for end-to-end design of nucleic acid therapeutics. Bioinformatics. https://doi.org/10.1093/bioinformatics/btag815

Vancouver

Kubis J, Boinski P, Antczak M, Figlerowicz MM, Szachniuk M, Figiel M. BIOREDIS: an integrated platform for end-to-end design of nucleic acid therapeutics. Bioinformatics. 2026. doi:10.1093/bioinformatics/btag815

BibTeX
@article{Kubis2026,
  author = {Kubis, Jakub and Boinski, Pawel and Antczak, Maciej and Figlerowicz, Marek M and Szachniuk, Marta and Figiel, Maciej},
  title = {BIOREDIS: an integrated platform for end-to-end design of nucleic acid therapeutics},
  journal = {Bioinformatics},
  year = {2026},
  doi = {10.1093/bioinformatics/btag815}
}
Kostenlos starten →